Counterfeit Drugs

Bristol-Myers Squibb is committed to ensuring the safety and integrity of its products as part of its mission to help patients prevail against serious diseases.
Counterfeit drugs represent a threat to the Bristol-Myers Squibb pledge to provide our customers with the safest, most effective and highest quality products. There is no single solution to this issue; however, Bristol-Myers Squibb has efforts in place to help ensure the integrity of our products and further patient safety:
- An integrated team addresses counterfeiting issues
- Product security technology to make our packaging and products less vulnerable to counterfeiting
- Participation in industry coalitions and organizations addressing this issue
- Collaboration with supply chain vendors and law enforcement agencies on product security matters
Counterfeit Drugs and Travel
U.S. Food and Drug Administration: Counterfeit Medicines
Partnership for Safe Medicines
Buy Safe Drugs
IMPACT! International Medical Products Anti-Counterfeiting Taskforce
World Health Organization (WHO): Counterfeit Medicines
World Health Organization (WHO): Counterfeit Medicines Fact Sheet